Please login to the form below

Not currently logged in
Email:
Password:

lecanemab

This page shows the latest lecanemab news and features for those working in and with pharma, biotech and healthcare.

New report identifies key issues with NICE’s methods for evaluating Alzheimer’s drugs

New report identifies key issues with NICE’s methods for evaluating Alzheimer’s drugs

While there are currently no licensed DMDTs in the UK, several are at varying stages of development and regulatory approval, including Eisai and Biogen’s lecanemab and Eli Lilly’s donanemab.

Latest news

More from news
Approximately 7 fully matching, plus 17 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...